Previous Article | Next Article 
Journal of Clinical Microbiology, July 1998, p. 1907-1911, Vol. 36, No. 7
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Effects of Different Test Conditions on MICs of
Food Animal Growth-Promoting Antibacterial Agents for
Enterococci
Patrick
Butaye,*
Luc
A.
Devriese, and
Freddy
Haesebrouck
Laboratory of Bacteriology and Mycology,
Department of Pathology, Bacteriology and Avian Diseases, Faculty
of Veterinary Medicine, University of Ghent, B-9820 Merelbeke, Belgium
Received 23 September 1997/Returned for modification 31 December
1997/Accepted 7 April 1998
 |
ABSTRACT |
The influence of the addition of sheep blood to Mueller-Hinton II
agar and the effects of aerobic incubation with or without CO2 and of anaerobic incubation were tested with
bacitracin, tylosin, avoparcin, virginiamycin, avilamycin, narasin, and
flavomycin on enterococci. The antibacterial activity of bambermycin
(Flavomycin) was strongly inhibited by the addition of blood, except
with the species Enterococcus faecium, Enterococcus
mundtii, Enterococcus hirae, Enterococcus
casseliflavus, and Enterococcus gallinarum, which
were not susceptible to this antibiotic on blood-free medium. With all
other antimicrobials except avoparcin and tylosin, the presence of
blood resulted in MIC increases of 1 to 3 log2 differences. Incubation in aerobic or anaerobic atmospheres enriched with
CO2 lowered the susceptibility of enterococci to tylosin
and increased their susceptibility to avilamycin, narasin, and
avoparcin. This effect was most pronounced in tests on blood-free
media. Results of susceptibility tests incubated under anaerobiosis and
in a CO2-enriched atmosphere did not differ. For all
enterococcal species, the preferred conditions for testing the
susceptibility are Mueller-Hinton II medium supplemented with blood and
incubation in a CO2-enriched atmosphere. However, when only
E. faecium and Enterococcus faecalis are
being tested, Mueller-Hinton II medium without blood incubated aerobically gives satisfactory results.
 |
INTRODUCTION |
Several enterococcal species belong
to the normal intestinal flora of humans and animals.
Enterococcus faecalis, Enterococcus faecium, and
more rarely other species may be involved in human infections.
Antibiotic therapy is problematic because of resistances. In
particular, penicillin, aminoglycoside, and glycopeptide resistances cause problems (12, 15).
To date, in animals, enterococcal infections are not known to play an
important role, possibly because geriatric medicine and intensive care
are less well developed. Recently the susceptibility of these
intestinal bacteria to food animal growth-promoting antimicrobial agents not used in therapy has become a subject of concern (1, 11,
18). However, few data on the in vitro susceptibility of
intestinal bacteria to these agents are available (7).
Enterococci from animals have been tested for susceptibility and
resistance to growth promoters and therapeutic agents by the disc
diffusion method (13), agar dilution tests in Mueller-Hinton
agar (6), and the broth dilution method (18).
These differences in test methods make test results difficult to
compare.
Enterococci need rich media for rapid growth (3). Most
probably because the usual standardized Mueller-Hinton II medium was
unsatisfactory in this respect, a modification of culture conditions,
consisting of the use of brain heart infusion, was suggested by the
National Committee for Clinical Laboratory Standards (NCCLS) (standard
M100-S7 for use with M7-A4) (14) for testing resistance of
E. faecalis and E. faecium to
gentamicin, streptomycin, and vancomycin. This complex medium has not
been standardized for antibiotic susceptibility testing, and
differences may occur between different manufacturers. Furthermore,
several species of enterococci belonging to the normal flora of animals
require special growth conditions. A CO2-enriched
environment is necessary for the growth of Enterococcus
columbae and Enterococcus cecorum (4). Other
species show enhanced growth when incubated in a CO2-enriched environment. The natural habitat of the
intestinal enterococci is, however, largely anaerobic, and these
facultative anaerobic bacteria have a preference for anaerobic
conditions (3). These special requirements imply a need for
specialized culture conditions.
The activity of several antibiotics is known to be influenced by the
composition of the medium and/or by the incubation conditions. The
possible effects of the composition of the medium and/or incubation conditions are much less well-known for the growth-promoting
antibacterials. The only well-known phenomenon involving these
substances is the influence of CO2 on the pH of the medium,
which affects the activity of tylosin, a macrolide antibiotic (9,
10, 16).
Therefore, we wished to investigate the effects of different
modifications of the standardized Mueller-Hinton II agar dilution procedure on inhibitory activity of growth promoters. Such
modifications have been proposed by the NCCLS for use with fastidious
bacteria (standard M100-S7 for use with M7-A4) (14). The
effects of sheep blood (5%), CO2 incubation, and
anaerobic incubation on the MICs of seven growth-promoting agents used
in Europe for collection strains of animal-associated species of the
genus Enterococcus were determined.
 |
MATERIALS AND METHODS |
Strains.
The tested collection strains of intestinal
enterococci belonging to different species groups are shown in Table
1 (5, 21). The E. faecalis ATCC 29212 and Staphylococcus aureus ATCC 29213 control strains used for susceptibility tests were included in
all tests.
Antibiotics.
The following antibiotic preparations,
manufactured for analytical purposes, were tested: avoparcin (American
Cyanamid, Princeton, N.J.), bambermycin (Flavomycin; Hoechst,
Frankfurt, Germany), virginiamycin (Pfizer, Rixensart, Belgium),
bacitracin (67,000 U/mg) (Sigma, St. Louis, Mo.), tylosin (Sigma),
avilamycin (Eli Lilly, Indianapolis, Ind.), and narasin (Eli Lilly).
Antibiotics were dissolved in appropriate solvents to make stock
solutions containing 1,000 µg/ml and then further diluted in sterile
distilled water according to the methods recommended by the NCCLS
(standard M100-S7 for use with M7-A4) (14).
Antimicrobial susceptibility tests.
MIC tests were carried
out on Mueller-Hinton II agar (Becton Dickinson, Cockeysville, Md.)
with or without 5% sheep blood containing doubling dilutions of the
antibiotics and used on the day of preparation. Appropriate
antibiotic-free agar plates were included as controls. Inocula were
prepared by diluting brain heart infusion (Oxoid, Basingstoke, United
Kingdom) cultures in buffered saline overnight to a density of 0.5 on
the McFarland turbidity scale and diluted 40-fold before inoculation.
Plates were seeded with approximately 105 CFU.
Plates with or without sheep blood added were incubated aerobically,
anaerobically (GasPak Plus; Becton Dickinson) with more
than 4% but
less than 10% CO
2, or in a CO
2 (5%)-enriched
aerobic
environment for 24 h.
 |
RESULTS |
Effect of blood supplementation.
When plates were incubated
aerobically, major differences between Mueller-Hinton media with and
without blood were noted in bambermycin MICs for several strains (44%
of the strains) (Table 2). This increase
in MIC on blood-containing media was not evident in the range of
concentrations tested with strains for which MICs obtained on
blood-free media were high. These all belonged to the E. faecium and E. gallinarum species groups. Narasin
MICs were almost systematically (72% of the strains) 2 or 3 doubling dilutions higher on blood-supplemented agar. With bacitracin, differences of 1 or 2 doubling dilutions were seen with most strains (72%), and for some strains, a much higher MIC was seen when blood was
added. With virginiamycin and avilamycin, the MIC was 1 or 2 doubling
dilutions higher for 48 and 44% of the strains, respectively. With
avoparcin and tylosin, no important differences were found. It should
be noted that none of the strains of the E. cecorum group grew in these aerobically incubated tests. The same was seen with
certain of the E. avium group strains but only on
blood-free media.
View this table:
[in this window]
[in a new window]
|
TABLE 2.
Log2 differences in the comparison of test
results on Mueller-Hinton II medium either supplemented with 5%
sheep blood or not supplemented
|
|
All strains grew when incubations were performed anaerobically (Table
2), and differences regarding blood supplementation
effects were
similar to those seen in the aerobically incubated
tests. For
bambermycin, major differences were seen in 61% of
the strains tested.
Virginiamycin, avilamycin, and bacitracin
tended to have MICs 1 doubling dilution higher on blood-supplemented
media for most of the
strains (60, 80, and 76%, respectively).
With narasin, the effect of
blood was the same as that observed
when plates were incubated
aerobically. Tylosin MICs were only
slightly different for
24% of the strains.
Upon incubation in a CO
2-enriched atmosphere (Table
2), the
same tendencies in MIC differences were seen as when incubation
was
performed anaerobically.
Anaerobic versus aerobic incubation.
When blood-supplemented
plates were used (Table 3), the
antibiotics bambermycin, avilamycin, narasin, and avoparcin showed slightly higher MICs upon anaerobic incubation than upon aerobic incubation for 27, 30, 65, and 34% of the strains, respectively. With
tylosin, the opposite was seen in 46% of the strains tested. For
virginiamycin and bacitracin, there was an almost equal distribution between higher and lower MICs when the aerobic test results were compared with the anaerobic ones.
View this table:
[in this window]
[in a new window]
|
TABLE 3.
Log2 differences in the comparison of test
results from incubation occurring aerobically and anaerobically
|
|
No uniform effect of anaerobic incubation was seen on
Mueller-Hinton plates without blood supplement (Table
3). Avilamicin,
narasin, and avoparcin had slightly lower MICs when incubated
anaerobically for 64, 84, and 52% of the strains, respectively.
Virginiamycin and bacitracin anaerobic and aerobic test results
did not
differ, while tylosin showed a tendency that was again
opposite to that
of the other antibiotics tested: MICs for 40%
of the strains were
higher when the strains were incubated anaerobically.
Aerobic incubation versus incubation in a CO2-enriched
atmosphere.
On Mueller-Hinton plates supplemented with blood, no
major differences were noted (Table 4).
For avilamycin, narasin, avoparcin, and to a lesser
extent bacitracin, there was a tendency towards slightly lower
MICs on plates incubated in CO2 with 46, 77, 58, and 31%
of the strains, respectively. In tests with tylosin, the opposite
was seen with 50% of the strains. Bambermycin and virginiamycin results did not differ when strains were incubated aerobically or in a
CO2-enriched atmosphere.
View this table:
[in this window]
[in a new window]
|
TABLE 4.
Log2 differences in the comparison of test
results from incubation occurring aerobically and in a
CO2-enriched atmosphere
|
|
When Mueller-Hinton plates without blood were used (Table
4),
differences between results obtained with aerobic incubation
and
in a CO
2-enriched atmosphere were relatively unimportant
and
similar to the ones noted in the comparative tests with
anaerobic
incubation.
Anaerobic incubation versus incubation in a
CO2-enriched atmosphere.
Between anaerobic incubation
or incubation in a CO2-enriched atmosphere, there were no
substantial differences in MIC results on plates with and without blood
(Table 5).
View this table:
[in this window]
[in a new window]
|
TABLE 5.
Log2 differences in the comparison of test
results from incubation occurring anaerobically and in a
CO2-enriched atmosphere
|
|
MICs obtained in tests on Mueller-Hinton II with blood and incubated in
5% CO
2 are tabulated in Table
6.
View this table:
[in this window]
[in a new window]
|
TABLE 6.
MICs of different growth-promoting antibiotics for
enterococci tested on blood-supplemented Mueller-Hinton II agar and
incubated in CO2
|
|
 |
DISCUSSION |
Blood supplementation of Mueller-Hinton plates has been shown to
have an effect on the MICs of sulfonamide, trimethoprim, cephalosporins, novobiocin, and nafcillin for enterococci
(22). The addition of blood reduces MICs of cephalosporins,
but not all cephalosporins react in the same way: some remain
unaffected, and for others the effect does not exceed 1 or 2 doubling
dilutions. This is dependent on the chemical structure of the
cephalosporins (2, 17). In the present study, major
detrimental effects of blood on antibacterial activity were seen with
bambermycin. In the original description of this antibiotic
(20), which at that time was called moenomycin, it was
indicated that serum inactivates its in vitro activity by 10 to 0.1%
compared to protein-free medium. The effects of blood seen in the
present tests were much more dramatic, at least on the inhibitory
activity on species and strains which were susceptible to
relatively low concentrations of this antibiotic. A similar
effect of blood may possibly be found in higher concentration
ranges for the other strains.
Few reports deal with the effects of anaerobic incubation on MIC
results. The activity of aminoglycosides is significantly reduced with
Escherichia coli, Klebsiella pneumoniae and
Proteus mirabilis incubated anaerobically without
CO2 (19). The reason for the negative effect on
tylosin activity is found in the presence of CO2, which has
an effect on the pH of the medium (9, 10, 16). The causes of
the slightly positive effects of CO2 and anaerobic
incubation on the inhibitory activity of avilamycin, narasin, and
avoparcin observed in the present investigation are unknown, though
they are most probably found in the effect of CO2 on the
activity of the antibiotics. To our knowledge, nothing is known about a
pH effect on the MICs of these growth promoters. The activity of
bambermycin has been reported to be affected by pH increases
(20). This was not evident in our tests on blood-containing media, not even with strains such as the S. aureus control
strain and the few other strains that were inhibited by relatively low concentrations of bambermycin in this medium (Table 6). The effects of
this antibiotic on blood-free medium were strongly variable and strain
dependent. It should be noted that the comparisons between aerobic
incubation results and the results obtained in aerobic or aerobic
CO2-supplemented atmospheres are somewhat hindered by the
presence of E. cecorum and of E. avium
group strains which did not grow or which grew poorly aerobically.
These strains were not included in the comparative tables.
Many changes in MICs corresponded to the species groups, or to several
species of a species group, indicating that there may be
species-specific growth requirements and that the species-specific metabolism may play a role in the differences noted. For the
capnophilic bacteria, CO2 dependency is clearly
species group related; none of the strains in the E. cecorum group grow without CO2, and some of the
strains in the E. avium group have such poor
growth without CO2 that MICs could not be evaluated.
However, for the other species-related changes, no obvious reason can
be found for the differences.
It can be concluded that Mueller-Hinton II agar can be used for testing
of the inhibitory activity of growth-promoting agents on enterococci.
The addition of blood decreases the activity of these products to
various degrees. The addition of CO2 under both aerobic and
anaerobic conditions enhances the inhibitory effects of narasin,
avoparcin, and avilamycin and is detrimental to the activity of
tylosin. When CO2 supplementation is necessary because capnophilic strains are to be tested, the choice between anaerobic incubation with 4 to 10% CO2 in the jars or incubation in
a CO2 incubator can be left open. The preferred conditions
for testing the susceptibility when all enterococcal species are being
compared is Mueller-Hinton II medium supplemented with blood and
incubated in a CO2-enriched atmosphere. When only
E. faecium and E. faecalis are being
tested, Mueller-Hinton II medium incubated aerobically gives
satisfactory results. It should be recognized, however, that the
omission of blood strongly influences results obtained with certain
antibiotics, especially bambermycin and narasin.
 |
ACKNOWLEDGMENTS |
This work has been supported by the Research Fund of the
University of Ghent, Codenr. BOZF97/N2/022.
We thank A. Van de Kerckhove for her skilled technical assistance.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: University of
Ghent, Faculty of Veterinary Medicine, Department of Pathology,
Bacteriology and Avian Diseases, Laboratory of Bacteriology and
Mycology, Salisburylaan 133, B-9820 Merelbeke, Belgium. Phone: 32 9 264 74 35. Fax: 32 9 264 74 94. E-mail:
pbutaye{at}allserv.rug.ac.be.
 |
REFERENCES |
| 1.
|
Bates, J.,
J. Z. Jordans, and D. T. Griffiths.
1994.
Farm animals as a putative reservoir for vancomycin-resistant enterococcal infection in man.
J. Antimicrob. Chemother.
34:507-514[Abstract/Free Full Text].
|
| 2.
|
Buschelman, B. J.,
R. N. Jones, and M. B. Bale.
1994.
Effects of blood medium supplementation on activities of newer cephalosporins tested against enterococci.
J. Clin. Microbiol.
32:565-567[Abstract/Free Full Text].
|
| 3.
|
Devriese, L. A.,
M. D. Collins, and R. Wirth.
1991.
The genus Enterococcus, p. 1465-1481.
In
A. Balows, H. G. Trüper, M. Dworkin, W. Harder, and K.-H. Schleifer (ed.), The prokaryotes, 2nd ed., vol. II. Springer-Verlag, New York, N.Y.
|
| 4.
|
Devriese, L. A.,
K. Ceyssens, and F. Haesebrouck.
1991.
Characteristics of Enterococcus cecorum strains from the intestines of different animal species.
Lett. Appl. Microbiol.
12:137-139.
|
| 5.
|
Devriese, L. A.,
B. Pot, and M. D. Collins.
1993.
Phenotypic identification of the genus Enterococcus and differentiation of phylogenetically distinct enterococcal species and species groups.
J. Appl. Bacteriol.
75:399-408[Medline].
|
| 6.
|
Dutta, G. N., and L. A. Devriese.
1982.
Susceptibility of fecal streptococci of poultry origin to nine growth-promoting agents.
Appl. Environ. Microbiol.
44:832-837[Abstract/Free Full Text].
|
| 7.
|
Dutta, G. N., and L. A. Devriese.
1984.
Observations on the in vitro sensitivity and resistance of Gram positive intestinal bacteria of farm animals to growth promoting antimicrobial agents.
J. Appl. Bacteriol.
56:117-123[Medline].
|
| 8.
|
Evers, S.,
R. Quintiliani, and P. Courvalin.
1996.
Genetics of resistance in enterococci.
Microb. Drug Resist.
2:219-223.
[Medline] |
| 9.
|
Goldstein, E. J., and V. L. Sutter.
1983.
Effect of carbon dioxide on erythromycin.
Antimicrob. Agents Chemother.
23:325-327[Abstract/Free Full Text].
|
| 10.
|
Hansen, S. L.,
P. Swomley, and G. Drusano.
1981.
Effect of carbon dioxide and pH on the susceptibility of Bacteroides fragilis group to erythromycin.
Antimicrob. Agents Chemother.
19:335-336[Abstract/Free Full Text].
|
| 11.
|
Klare, I.,
H. Heier,
H. Claus,
R. Reissbrodt, and W. Witte.
1995.
vanA-mediated high-level glycopeptide resistance in Enterococcus faecium from animal husbandry.
FEMS Microbiol. Lett.
125:165-171[Medline].
|
| 12.
|
Klare, I.,
H. Heier,
H. Claus,
G. Böhme,
S. Marin,
G. Seltmann,
R. Hakenbeck,
V. Antanassova, and W. Witte.
1995.
Enterococcus faecium strains with vanA-mediated high-level glycopeptide resistance isolated from animal food stuffs and fecal samples of humans in the community.
Microb. Drug Resist.
1:265-272.
[Medline] |
| 13.
|
Linton, A. H.,
M. H. Hinton, and Z. A. M. Al-Chalaby.
1985.
Monitoring for antibiotic resistance in enterococci consequent upon feeding growth promoters active against Gram-positive bacteria.
J. Vet. Pharmacol. Ther.
8:62-70[Medline].
|
| 14.
|
National Committee for Clinical Laboratory Standards.
1997.
Approved standard M7-A4. Scheme for preparing dilutions of antimicrobial agents to be used in agar dilution susceptibility tests. Suggested modifications of standard methods for susceptibility testing of some fastidious and special problem bacteria (M100-S7).
National Committee for Clinical Laboratory Standards, Wayne, Pa.
|
| 15.
| Nicoletti, G., and S. Stefani. 1995. Enterococci:
susceptibility patterns and therapeutic options. Eur. J. Clin.
Microbiol. Infect. Dis. 1(Suppl.):33-37.
|
| 16.
|
Omura, S., and H. Tanaka.
1984.
Production and antimicrobial activity of macrolides, p. 3-35.
In
S. Omura (ed.), Macrolide antibiotics. Academic Press, Orlando, Fla.
|
| 17.
|
Sahm, D. F.,
C. N. Baker,
R. N. Jones, and C. Thornsberry.
1983.
Medium-dependent zone size discrepancies associated with susceptibility testing of group D streptococci against various cephalosporins.
J. Clin. Microbiol.
18:858-865[Abstract/Free Full Text].
|
| 18.
|
Thal, L. A.,
J. W. Chow,
R. Mahayni,
H. Bonilla,
M. B. Perri,
S. A. Donabedian,
J. Silverman,
S. Taber, and M. J. Zervos.
1995.
Characterization of antimicrobial resistance in enterococci of animal origin.
Antimicrob. Agents Chemother.
39:2112-2115[Abstract].
|
| 19.
|
Verklin, R. M., and G. L. Mandell.
1977.
Alteration of effectiveness of antibiotics by anaerobiosis.
J. Lab. Clin. Med.
89:65-71[Medline].
|
| 20.
| Wasielewski, E. V., R. Mushaweck, and E. Schütze. 1966. Moenomycin, a new antibiotic. III. Biological
properties, p. 743-748. Antimicrob. Agents Chemother. 1965.
|
| 21.
|
Williams, A. M.,
U. M. Rodrigues, and M. D. Collins.
1991.
Intragenic relationships of Enterococci as determined by reverse transcriptase sequencing of small-subunit rRNA.
Res. Microbiol.
142:67-74[Medline].
|
| 22.
|
Woods, G. L., and J. A. Washington.
1995.
Antibacterial susceptibility tests: dilution and disk diffusion methods, p. 1327-1341.
In
P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.), Manual of clinical microbiology, 6th ed. ASM Press, Washington, D.C.
|
Journal of Clinical Microbiology, July 1998, p. 1907-1911, Vol. 36, No. 7
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Butaye, P., Devriese, L. A., Haesebrouck, F.
(2003). Antimicrobial Growth Promoters Used in Animal Feed: Effects of Less Well Known Antibiotics on Gram-Positive Bacteria. Clin. Microbiol. Rev.
16: 175-188
[Abstract]
[Full Text]
-
Butaye, P., Devriese, L. A., Haesebrouck, F.
(2001). Differences in Antibiotic Resistance Patterns of Enterococcus faecalis and Enterococcus faecium Strains Isolated from Farm and Pet Animals. Antimicrob. Agents Chemother.
45: 1374-1378
[Abstract]
[Full Text]
-
Butaye, P., Devriese, L. A., Haesebrouck, F.
(2000). Influence of different medium components on the in vitro activity of the growth-promoting antibiotic flavomycin against enterococci. J Antimicrob Chemother
46: 713-716
[Abstract]
[Full Text]
-
Chalker, A. F., Ingraham, K. A., Lunsford, R. D., Bryant, A. P., Bryant, J., Wallis, N. G., Broskey, J. P., Pearson, S. C., Holmes, D. J.
(2000). The bacA gene, which determines bacitracin susceptibility in Streptococcus pneumoniae and Staphylococcus aureus, is also required for virulence. Microbiology
146: 1547-1553
[Abstract]
[Full Text]
-
Butaye, P., Devriese, L. A., Haesebrouck, F.
(1999). Phenotypic Distinction in Enterococcus faecium and Enterococcus faecalis Strains between Susceptibility and Resistance to Growth-Enhancing Antibiotics. Antimicrob. Agents Chemother.
43: 2569-2570
[Abstract]
[Full Text]